Skip to main content

DSM and Firmenich in mega-merger

6th June 2022

Submitted by:

Andrew Warmington

DSM and Swiss-based flavours and fragrances house Firmenich have agreed to merge. The deal, which is expected to close in 1H 2023, is valued at about $19.6 billion. DSM-Firmenich would have about €11.4 billion/year in sales, comparable to IFF after its combination with DuPont’s Nutrition and Biosciences business early last year.

The two firms have a combined network of 15 R&D facilities and a portfolio of more than 16,000 patents across. Although the merger has been positioned as one of equals, DSM shareholders will own 65.5% of the new firm. It will have four main businesses:

* Perfumery & Beauty, with combined revenues of €3.3 billion/year, combining Firmenich’s Perfumery & Ingredients business with DSM’s Personal Care & Aroma business

* DSM’s Food & Beverage plus Firmenich’s Taste & Beyond (€2.7 billion/year), which brings together their activities in food and beverage

* Health, Nutrition & Care (€2.2 billion/year), which will be active in the nutrition, dietary supplements, pharmaceuticals and medical devices markets

* Animal Nutrition & Health (€3.3 billion/year), supplying eubiotics, enzymes and mycotoxin risk management, among other things

“At DSM-Firmenich’s core will be deep science capabilities, with significant cross-fertilisation opportunities in bioscience, fermentation, green chemistry, receptor biology, sensory perception and formulation, augmented by analytical sciences, data sciences and artificial intelligence,” the two companies said.

Organic sales are expected to grow at 5-7% over the medium term, with high single-digit adjusted EBITDA growth. The EBITDA margin is expected to move to 22-23%, supported by run-rate pre-tax synergies of about €350 million/year of adjusted EBITDA by 2026. One-time implementation costs of about €250 million will be taken to realise synergies, particularly from the integration of the food and beverage business.

Thomas Leysen, current chairman of the DSM supervisory board, will be chairman, with Firmenich chairman Patrick Firmenich as vice-chairman. DSM co-CEOs Geraldine Matchett and Dimitri de Vreeze, will also be co-CEOs at the new firm, including CFO and COO responsibilities respectively. Emmanuel Butstraen, currently president of Taste & Beyond at Firmenich is to be chief integration officer.

Shortly before this, DSM had agreed to sell its Engineering Materials business to Advent International and Lanxess for an enterprise value of €3.85 billion. This concluded the process of selling its Materials businesses that began with the sale of DSM Protective Materials to Avient in April.

Helm, CAC Nantong expand partnership

Helm has reached an agreement with CAC Nantong Chemical to expand their global partnership. Under

Submitted by:

Andrew Warmington

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Sterling suite

CDMOs grow in ADCs

Reflecting the ongoing boom in the development antibody-drug conjugates (ADCs), two Western CDMOs announced expansions

Submitted by:

Andrew Warmington

Flamma Lundbeck

Flamma buys Lundbeck site

Italian CDMO Flamma has entered into an agreement to acquire Lundbeck Pharmaceuticals Italy (LuPI) from

Submitted by:

Andrew Warmington

Opening ceremony at UPM's biorefinery in Leuna

UPM opens biorefinery in Germany

UPM has inaugurated a biorefinery in Leuna, Germany, which will make up to 220,000 tonnes/year

Submitted by:

Andrew Warmington

Solenis pulp centre in Brazil

Solenis moves pulp centre

Solenis has relocated its Pulp Centre of Excellence from the US to a new facility

Submitted by:

Andrew Warmington

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Symrise facility in India

Symrise in double Asian expansion

Symrise has announced that it has opened its new Scent Creative Centre in Singapore and

Submitted by:

Andrew Warmington

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Lanxess to continue pigment production

Lanxess has reversed a decision to sell the chromium oxide pigments business at the Krefeld-Uerdingen

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

Semiconductor manufacturing

Sumitomo Chemical works with Tata

Sumitomo Chemical has signed a Memorandum of Understanding with India’s Tata Electronics to explore a

Submitted by:

Andrew Warmington

FramoChem and VanDeMark are separated

VanDeMark separation is complete

Japan’s Hodogaya Chemical has completed the previously announced acquisition of Hungarian API and intermediates producer

Submitted by:

Andrew Warmington